| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |